Cited by 339Per- and polyfluoroalkyl substances researchImmunotoxicology and immune responsesBirth, Development, and Health

Pre-natal Exposure to Perfluoroalkyl Substances May Be Associated with Altered Vaccine Antibody Levels and Immune-Related Health Outcomes in Early Childhood

Open access
Granum, Berit, Haug, Line S., Namork, Ellen, Stølevik, Solvor B., Thomsen, Cathrine, Aaberge, Ingeborg S., van Loveren, Henk, Løvik, Martinus +1 more·2013·Journal of Immunotoxicology

Abstract

Perfluoroalkyl substances (PFAS) are suggested to have immunosuppressive effects; exposure in utero and in the first years of life is of special concern as fetuses and small children are highly vulnerable to toxicant exposure. The objective of this study was to investigate the effect of pre-natal exposure to PFAS on responses to pediatric vaccines and immune-related health outcomes in children up to 3 years of age. In the prospective birth-cohort BraMat, a sub-cohort of the Norwegian Mother and Child Cohort Study (MoBa), pregnant women from Oslo and Akershus, Norway, were recruited during 2007-2008. Three annual questionnaire-based follow-ups were performed. Blood samples were collected from the mothers at the time of delivery and from the children at the age of 3 years. As a measure of pre-natal exposure to PFAS, the concentrations of perfluorooctanoate (PFOA), perfluorononanoate (PFNA), perfluorohexane sulfonate (PFHxS), and perfluorooctane sulfonate (PFOS) were determined in maternal blood from 99 BraMat participants. Main outcome measures were anti-vaccine antibody levels, common infectious diseases and allergy- and asthma-related health outcomes in the children up to the age of 3 years. There was an inverse association between the level of anti-rubella antibodies in the children's serum at age 3 years and the concentrations of the four PFAS. Furthermore, there was a positive association between the maternal concentrations of PFOA and PFNA and the number of episodes of common cold for the children, and between PFOA and PFHxS and the number of episodes of gastroenteritis. No associations were found between maternal PFAS concentrations and the allergy- and asthma-related health outcomes investigated. The results indicate that pre-natal exposure to PFAS may be associated with immunosuppression in early childhood.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/1547691x.2012.755580

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A number of studies have demonstrated that elevated concentrations of PFAS can lead to immunosuppression, increased severity of infections, and decreased response to vaccines.

    “A number of studies have demonstrated that elevated concentrations of PFAS can lead to immunosuppression, increased severity of infections, and decreased response to vaccines”

    From A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior (2022) · cites this paper as Granum et al., 2013

    The Discussion and Conclusion associate higher prenatal PFAS exposure with lower rubella-vaccine antibody levels, more episodes of common cold and gastroenteritis, and possible immunosuppression. They report infection frequency, not severity, and describe associations rather than demonstrating that PFAS causes these outcomes. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Granum, B., Haug, L. S., Namork, E., Stølevik, S. B., Thomsen, C., Aaberge, I. S., van Loveren, H., Løvik, M., & Nygaard, U. C.
Affiliations
Norwegian Institute of Public Health (NO)
Corresponding author
Granum, Berit
Venue
Journal of Immunotoxicology
Published
2013-01-25
Volume
10
Issue
4
Pages
373-379
ISSN
  • 1547-6901 (ISSN-L)
  • 1547-691X
OpenAlex
W2064994678
Cited by
339
References
34
Citations by year
2026: 20 · 2025: 36 · 2024: 36 · 2023: 28 · 2022: 31 · 2021: 36 · 2020: 33 · 2019: 26 · 2018: 21 · 2017: 19 · 2016: 18 · 2015: 19 · 2014: 9 · 2013: 5
FWCI
13.59
Type
journal article
Language
en
Open access
Locations
  • Journal of Immunotoxicology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
Funders
Norwegian Institute of Public Health
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
perfluorinated compounds, prenatal exposure, immunosuppression, vaccine antibody response, rubella antibodies, perfluorooctanoic acid, PFNA, PFHxS, PFOS, common cold, gastroenteritis, pediatric allergy, childhood asthma
MeSH terms
Alkenes, Antibodies, Viral, Asthma, Caprylates, Child, Preschool, Common Cold, Female, Fluorocarbons, Follow-Up Studies, Gastroenteritis, Humans, Hypersensitivity, Immunosuppression Therapy, Male, Norway, Pregnancy, Prenatal Exposure Delayed Effects, Prospective Studies, Vaccines, Cohort Studies, Incidence, Prevalence, Treatment Outcome, Alkanesulfonic Acids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review